• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 microRNA-21 和 microRNA-143 的减少与肺动脉高压有关。

Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.

机构信息

Department of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkey.

Department of Cardiology, Faculty of Medicine, Ege University, İzmir, Turkey.

出版信息

Turk J Med Sci. 2023 Feb;53(1):130-141. doi: 10.55730/1300-0144.5566. Epub 2023 Feb 22.

DOI:10.55730/1300-0144.5566
PMID:36945942
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10388131/
Abstract

BACKGROUND

Pulmonary arterial hypertension (PAH) is characterized by maladaptation of pulmonary vasculature which is leading to right ventricular hypertrophy and heart failure. miRNAs play a crucial role in the regulation of many diseases such as viral infection, cancer, cardiovascular diseases, and pulmonary hypertension (PH). In this study, we aimed to investigate the expression pattern of eight human plasma miRNAs (hsa-miR-21-3p, hsa-miR-143- 3p, hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204-3p, hsamiR-206, hsa-miR-210-3p) in mild-to-severe PH patients and healthy controls.

METHODS

: miRNAs were extracted from the peripheral plasma of the PH patients (n: 44) and healthy individuals (n: 30) by using the miRNA Isolation Kit. cDNA was synthesized using All in-One First strand cDNA Synthesis Kit. Expression of the human plasma hsa-miR- 21-3p, hsa-miR-143-3p, hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204- 3p, hsa-miR-206, hsa-miR210-3p, and miRNAs were analyzed by qRT-PCR.

RESULTS

According to our results, in PH patients hsa-miR-21-3p and hsa-miR-143-3p expression levels were decreased by 4.7 and 2.3 times, respectively. No significant changes were detected in hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204-3p, hsamiR-206, and hsa-miR-210-3p expression levels between PH and control groups. In addition, considering the severity of the disease, it was observed that the decrease in miR-138, miR-143, miR-145, miR-190, mir-204, mir-206 and miR-208 expressions was significant in patients with severe PH.

DISCUSSION

: In the early diagnosis of PAH, hsa-miR-21-3p and especially hsa-miR-143-3p in peripheral plasma can be considered as potential biomarkers.

摘要

背景

肺动脉高压(PAH)的特征是肺血管的适应不良,导致右心室肥大和心力衰竭。miRNA 在许多疾病的调节中起着至关重要的作用,如病毒感染、癌症、心血管疾病和肺动脉高压(PH)。在这项研究中,我们旨在研究八种人类血浆 miRNA(hsa-miR-21-3p、hsa-miR-143-3p、hsa-miR-138-5p、hsa-miR-145-3p、hsa-miR-190a、hsa-miR-204-3p、hsamiR-206、hsa-miR-210-3p)在轻度至重度 PH 患者和健康对照者中的表达模式。

方法

通过使用 miRNA 分离试剂盒从 PH 患者(n=44)和健康个体(n=30)的外周血浆中提取 miRNA。使用 All in-One First strand cDNA Synthesis Kit 合成 cDNA。通过 qRT-PCR 分析人类血浆 hsa-miR-21-3p、hsa-miR-143-3p、hsa-miR-138-5p、hsa-miR-145-3p、hsa-miR-190a、hsa-miR-204-3p、hsa-miR-206、hsa-miR210-3p 和 miRNA 的表达。

结果

根据我们的结果,在 PH 患者中,hsa-miR-21-3p 和 hsa-miR-143-3p 的表达水平分别降低了 4.7 倍和 2.3 倍。在 PH 组和对照组之间,hsa-miR-138-5p、hsa-miR-145-3p、hsa-miR-190a、hsa-miR-204-3p、hsamiR-206 和 hsa-miR-210-3p 的表达水平没有显著变化。此外,考虑到疾病的严重程度,在严重 PH 患者中,miR-138、miR-143、miR-145、miR-190、mir-204、mir-206 和 mir-208 的表达降低具有显著性。

讨论

在 PAH 的早期诊断中,外周血浆中的 hsa-miR-21-3p 特别是 hsa-miR-143-3p 可以作为潜在的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/d567c5380e6d/turkjmedsci-53-1-130f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/9e289227aad0/turkjmedsci-53-1-130f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/e92b4cc2b020/turkjmedsci-53-1-130f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/b60298e32cfb/turkjmedsci-53-1-130f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/0cc939f03136/turkjmedsci-53-1-130f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/b9f74531a3ce/turkjmedsci-53-1-130f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/eb1c38884c21/turkjmedsci-53-1-130f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/d567c5380e6d/turkjmedsci-53-1-130f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/9e289227aad0/turkjmedsci-53-1-130f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/e92b4cc2b020/turkjmedsci-53-1-130f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/b60298e32cfb/turkjmedsci-53-1-130f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/0cc939f03136/turkjmedsci-53-1-130f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/b9f74531a3ce/turkjmedsci-53-1-130f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/eb1c38884c21/turkjmedsci-53-1-130f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce8a/10388131/d567c5380e6d/turkjmedsci-53-1-130f7.jpg

相似文献

1
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.循环 microRNA-21 和 microRNA-143 的减少与肺动脉高压有关。
Turk J Med Sci. 2023 Feb;53(1):130-141. doi: 10.55730/1300-0144.5566. Epub 2023 Feb 22.
2
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.口腔液(唾液和龈沟液)中的 microRNAs 作为正畸学中的生物标志物:系统评价和综合生物信息学分析。
Prog Orthod. 2021 Oct 11;22(1):31. doi: 10.1186/s40510-021-00377-1.
3
Identification of stable reference genes and differential miRNA expression in Sri Lankan type 2 diabetes mellitus patients: a cross-sectional study.斯里兰卡2型糖尿病患者中稳定参考基因的鉴定及微小RNA表达差异:一项横断面研究。
Front Endocrinol (Lausanne). 2025 Jun 12;16:1554827. doi: 10.3389/fendo.2025.1554827. eCollection 2025.
4
Non-invasive biomarkers for brain aging: the role of autophagy-related microRNAs in plasma exosomes.脑衰老的非侵入性生物标志物:自噬相关微小RNA在血浆外泌体中的作用
Front Mol Neurosci. 2025 Jun 6;18:1588007. doi: 10.3389/fnmol.2025.1588007. eCollection 2025.
5
Potential biomarker for screening nasopharyngeal carcinoma: three-microRNA panel in serum.用于筛查鼻咽癌的潜在生物标志物:血清中的三种微小RNA组合
Transl Cancer Res. 2025 Jun 30;14(6):3554-3564. doi: 10.21037/tcr-2024-2213. Epub 2025 Jun 26.
6
Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China.中国合肥汉族人群原发性高血压患者外周血miRNA表达情况
Biochem Genet. 2024 Jun 21. doi: 10.1007/s10528-024-10867-6.
7
Potential liquid biopsy markers of exosomal microRNAs in renal interstitial fibrosis blood and urine.肾间质纤维化血液和尿液中外泌体微小RNA的潜在液体活检标志物
Indian J Pathol Microbiol. 2025 Apr 1;68(2):279-286. doi: 10.4103/ijpm.ijpm_265_24. Epub 2024 Oct 17.
8
Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement.戈谢病患者外泌体微小RNA的表达谱及其与骨受累严重程度的关联
J Inherit Metab Dis. 2025 Jul;48(4):e70061. doi: 10.1002/jimd.70061.
9
Gene Coexpression and miRNA Regulation: A Path to Early Intervention in Colorectal Cancer.基因共表达和 miRNA 调控:结直肠癌早期干预的途径。
Hum Gene Ther. 2024 Oct;35(19-20):855-867. doi: 10.1089/hum.2023.207. Epub 2024 Jul 4.
10
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.2 型糖尿病患者循环血小板相关和糖尿病相关 microRNAs 的改变:逐步低血糖钳夹研究。
Cardiovasc Diabetol. 2022 May 20;21(1):79. doi: 10.1186/s12933-022-01517-5.

引用本文的文献

1
miRNAs in Pulmonary Hypertension: Mechanistic Insights and Therapeutic Potential.肺动脉高压中的微小RNA:机制洞察与治疗潜力
Biomedicines. 2025 Aug 5;13(8):1910. doi: 10.3390/biomedicines13081910.
2
Uncovering Hippo pathway-related biomarkers in acute myocardial infarction via scRNA-seq binding transcriptomics.通过单细胞RNA测序结合转录组学揭示急性心肌梗死中与河马通路相关的生物标志物
Sci Rep. 2025 Mar 26;15(1):10368. doi: 10.1038/s41598-025-94820-6.
3
MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.微小RNA作为女性不孕症的生物标志物和治疗靶点

本文引用的文献

1
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension.系统性硬皮病相关肺动脉高压患者的循环血浆 microRNAs。
Rheumatology (Oxford). 2021 Dec 24;61(1):309-318. doi: 10.1093/rheumatology/keab300.
2
Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges.肺动脉高压中的微小RNA分析:当前认知与挑战
JACC Basic Transl Sci. 2020 Nov 23;5(11):1149-1162. doi: 10.1016/j.jacbts.2020.07.008. eCollection 2020 Nov.
3
Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Int J Mol Sci. 2024 Dec 3;25(23):12979. doi: 10.3390/ijms252312979.
4
Variation and significance of serum microRNA-21 level in pediatric pulmonary artery hypertension associated with congenital heart disease.先天性心脏病相关小儿肺动脉高压血清微小RNA-21水平的变化及意义
Front Cardiovasc Med. 2024 Sep 5;11:1424679. doi: 10.3389/fcvm.2024.1424679. eCollection 2024.
5
Circ-0006332 stimulates cardiomyocyte pyroptosis via the miR-143/TLR2 axis to promote doxorubicin-induced cardiac damage.Circ-0006332通过miR-143/TLR2轴刺激心肌细胞焦亡,以促进阿霉素诱导的心脏损伤。
Epigenetics. 2024 Dec;19(1):2380145. doi: 10.1080/15592294.2024.2380145. Epub 2024 Jul 17.
6
Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus.高血压的表观遗传学作为 2 型糖尿病患者发生冠心病的危险因素。
Front Endocrinol (Lausanne). 2024 May 21;15:1365738. doi: 10.3389/fendo.2024.1365738. eCollection 2024.
7
Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis.鉴定血清中的 miR-30c-5p 微小 RNA 作为诊断子宫内膜异位症的候选生物标志物。
Int J Mol Sci. 2024 Feb 3;25(3):1853. doi: 10.3390/ijms25031853.
8
The regulatory role of microRNAs in common eye diseases: A brief review.微小RNA在常见眼病中的调控作用:简要综述。
Front Genet. 2023 Mar 29;14:1152110. doi: 10.3389/fgene.2023.1152110. eCollection 2023.
预防射血分数保留型心力衰竭(HFpEF):在寡核苷酸治疗时代重新审视 microRNA-21 抑制。
Cardiovasc Pathol. 2020 Nov-Dec;49:107243. doi: 10.1016/j.carpath.2020.107243. Epub 2020 May 19.
4
MicroRNA-143-5p modulates pulmonary artery smooth muscle cells functions in hypoxic pulmonary hypertension through targeting HIF-1α.微小 RNA-143-5p 通过靶向 HIF-1α 调节低氧性肺动脉高压肺动脉平滑肌细胞功能。
J Biosci. 2020;45.
5
Natural Heart Regeneration in a Neonatal Rat Myocardial Infarction Model.新生大鼠心肌梗死模型中的自然心脏再生。
Cells. 2020 Jan 16;9(1):229. doi: 10.3390/cells9010229.
6
MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension.微小 RNA-204 作为儿童先天性心脏病合并肺动脉高压严重程度的指标。
Med Sci Monit. 2019 Dec 30;25:10173-10179. doi: 10.12659/MSM.917662.
7
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
8
miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension.微小RNA-190a-5p通过靶向KLF15参与低氧诱导的肺动脉高压的调控,并可作为慢性阻塞性肺疾病合并肺动脉高压的诊断和预后生物标志物。
Int J Chron Obstruct Pulmon Dis. 2018 Nov 20;13:3777-3790. doi: 10.2147/COPD.S182504. eCollection 2018.
9
Recent research progress of microRNAs in hypertension pathogenesis, with a focus on the roles of miRNAs in pulmonary arterial hypertension.微小RNA在高血压发病机制中的最新研究进展,重点关注微小RNA在肺动脉高压中的作用。
Mol Biol Rep. 2018 Dec;45(6):2883-2896. doi: 10.1007/s11033-018-4335-0. Epub 2018 Oct 8.
10
Circulating MicroRNA Markers for Pulmonary Hypertension in Supervised Exercise Intervention and Nightly Oxygen Intervention.监督性运动干预和夜间氧疗干预中肺动脉高压的循环微小RNA标志物
Front Physiol. 2018 Jul 25;9:955. doi: 10.3389/fphys.2018.00955. eCollection 2018.